Sinopharm Group Co., Ltd.
http://www.sinopharmholding.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sinopharm Group Co., Ltd.
New Front-Runner Emerges In China mRNA Booster Race
China's CSPC Pharmaceutical Group surprises by announcing investigator-initiated trial results for SYS6006, its mRNA COVID-19 vaccine candidate against the Omicron variant.
Wuhan Back In Spotlight As Delta Variant Highlights Booster Shots Urgency
Amid surging infections in several cities including Wuhan, China is urging vaccination among unvaccinated people, but a booster shot may be needed soon to address a low efficacy among Chinese vaccines, some say.
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
‘Reckless’ State Campaigns Seek To Undermine Western COVID-19 Vaccines
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice